Latest AI and machine learning research in oncology/hematology for healthcare professionals.
BACKGROUND: The Phoenix definition is widely used to define biochemical recurrence (BCR) after radia...
The therapeutic landscape of colorectal cancer (CRC) has evolved with the identification of molecula...
BACKGROUND: Artificial intelligence (AI)-based computer-aided detection (CADe) systems improve adeno...
Perfluorooctanoic acid (PFOA), a persistent environmental pollutant, represents a chronic environmen...
BACKGROUND: Clavien-Dindo (CD) grade ≥II complications occur in roughly one in five patients after c...
CONTEXT: Statistical and artificial intelligence (AI)-based methods have informed clinical prognosti...
The ability to predict T-cell receptor (TCR) specificity from sequences could transform immunotherap...
Identification of minimally invasive biomarkers of cancer-associated cachexia may help to recognize ...
The precise segmentation of cervical cell images is regarded as a fundamental prerequisite for the i...
Although diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease, existing prognostic tools...
Treatment effectiveness is hindered by the phenotypic plasticity of cancer and the genetic complexit...
BACKGROUND: Gastric cancer (GC) remains a leading cause of cancer-related mortality worldwide, espec...
BACKGROUND: Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease often associ...
Cervical cancer is still a major public-health challenge, especially in low and middle-income countr...
Advanced pancreatic ductal adenocarcinoma (PDAC) often progresses rapidly during chemotherapy despit...
Cross-patient cell-type annotation in single-cell RNA sequencing (scRNA-seq) remains challenging due...
Single-cell proteomic data generated by mass spectrometry-based technologies provide direct insights...
Targeted drug delivery in the gastrointestinal tract remains challenging because therapeutics must o...
BACKGROUND: Glioblastoma (GBM) has an extremely poor prognosis, and its malignant progression is clo...
BACKGROUND: To investigate the feasibility of MRI-based habitat radiomics to differentiate indetermi...
BACKGROUND: Extrachromosomal circular DNA (eccDNA) is an emerging tumor biomarker notable for its tu...